Toxicity burden in older patients with chronic lymphocytic leukemia (CLL) receiving bendamustine with rituximab (BR) or ibrutinib (IB) regimens: Alliance A041202
- Citation:
- JCO vol 38 (no. 15_suppl) e20004
- Meeting Instance:
- ASCO 2020
- Year:
- 2020
- Type:
- Abstract
- Sub type:
- Published Only
- Funding:
- NCTN
- Endpoint:
- Secondary-not-in-original
- Analysis:
- Primary
- Data Sharing:
- No-Data-Sharing
- Status:
- Presented/Published
- Citation Status:
- epub
- Note:
- Methodological:
- No
- Biospecimen:
- No
- SDC:
- Yes
- Parents:
- None
- Children:
- 3416
- Pharmas:
- Pharmacyclics
- Grants:
- U10CA180821, U10CA180882, U24CA196171; U10CA180863 (CCTG);
- Corr. Author:
- Authors:
- Amy S. Ruppert Sumithra J. Mandrekar Allison M Booth Wei Ding Nancy L. Bartlett Danielle M. Brander Steven Coutre Jennifer R. Brown Sreenivasa Nattam Richard A. Larson Harry Erba Mark Litzow Carolyn Owen Charles Kuzma Jeremy S. Abramson Richard F. Little Scott Smith Richard M. Stone John C. Byrd Jennifer A. Woyach
- Networks:
- IL017, LAPS-IL057, LAPS-MA036, LAPS-MN026, LAPS-MO011, LAPS-NC010, LAPS-OH007, OH070, SCOR
- Study
- Alliance-A041202
- Multiple Studies, or Legacy Studies in Alliance Study:
- Phases:
- 3
- Keywords: